U.K. Aesthetic Injectable Market, 2026-2033
Global Market
Related Markets
UK aesthetic injectable market highlights
- The UK aesthetic injectable market generated a revenue of USD 493.1 million in 2025 and is expected to reach USD 1,037.3 million by 2033.
- The UK market is expected to grow at a CAGR of 9.7% from 2026 to 2033.
- In terms of segment, botulinum toxin (botox) was the largest revenue generating product in 2025.
- PLLA is the most lucrative product segment registering the fastest growth during the forecast period.
Aesthetic injectable market data book summary
| Market revenue in 2025 | USD 493.1 million |
| Market revenue in 2033 | USD 1,037.3 million |
| Growth rate | 9.7% (CAGR from 2026 to 2033) |
| Largest segment | Botulinum toxin (botox) |
| Fastest growing segment | PLLA |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Collagen and PMMA Microspheres, Hyaluronic Acid, Calcium Hydroxylapatite (CaHA), PLLA, PCL, PN/PDRN, Botulinum Toxin (Botox) |
| Key market players worldwide | Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc |
Other key industry trends
- In terms of revenue, UK accounted for 4.4% of the global aesthetic injectable market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, UK aesthetic injectable market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 1,037.3 million by 2033.
The growing number of nonsurgical procedures in the country is expected to boost the market over the forecast period. According to the ISAPS 2022 report, nearly 77,924 nonsurgical procedures were performed in the country, of which nearly 64,000 were injectable procedures.
In addition, nearly 35,000 botulinum toxin and 27,000 HA-based procedures were performed in 2022. According to the same report, an estimated 600 surgeons were registered nationwide. Moreover, the country is rapidly changing its regulations for aesthetic injectables due to practitioner malpractices.
For instance, in September 2023, a government consultation program was launched to improve the clinical practices related to dermal fillers and Botox procedures. According to government approved register Save Face, nearly 3,000 complaints were received in 2022, of which 65% to 67% were related to dermal fillers and nearly 25% were related to Botox.
No credit card required*
Publish Date: Apr 28, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Aesthetic Injectable Market
Aesthetic Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Galderma Group AG Registered Shares | View profile | - | Zählerweg 10, Zug, Switzerland, 6300 | www.galderma.com |
| Revance Therapeutics Inc | View profile | 597 | 1222 Demonbreun Street, Suite 2000, Nashville, TN, United States, 37203 | www.revance.com |
| Merz Pharma | View profile | 5001-10000 | Deutsch, Sachsen, Germany, Europe | www.merz.com |
| Suneva Medical | View profile | 101-250 | San Diego, California, United States, North America | sunevamedical.com |
| Prollenium Medical Technologies | View profile | 101-250 | Richmond Hill, Ontario, Canada, North America | prollenium.com |
| Sinclair Pharma plc | View profile | 501-1000 | London, England, United Kingdom, Europe | www.sinclairpharma.com/ |
| Medytox | View profile | 501-1000 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | www.medytox.com/page/company_en?site_id=en |
| Ipsen SA | View profile | 5,325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | www.ipsen.com |
U.K. Aesthetic Injectable Market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Aesthetic Injectable Market will help companies and investors design strategic landscapes.
Botulinum Toxin (Botox) was the largest segment with a revenue share of 50.21% in 2025.
Horizon Databook has segmented the U.K. aesthetic injectable market based on collagen and pmma microspheres, hyaluronic acid, calcium hydroxylapatite (caha), plla, pcl, pn/pdrn, botulinum toxin (botox) covering the revenue growth of each sub-segment from 2021 to 2033.
The growing number of nonsurgical procedures in the country is expected to boost the market over the forecast period. According to the ISAPS 2022 report, nearly 77,924 nonsurgical procedures were performed in the country, of which nearly 64,000 were injectable procedures.
In addition, nearly 35,000 botulinum toxin and 27,000 HA-based procedures were performed in 2022. According to the same report, an estimated 600 surgeons were registered nationwide. Moreover, the country is rapidly changing its regulations for aesthetic injectables due to practitioner malpractices.
For instance, in September 2023, a government consultation program was launched to improve the clinical practices related to dermal fillers and Botox procedures. According to government approved register Save Face, nearly 3,000 complaints were received in 2022, of which 65% to 67% were related to dermal fillers and nearly 25% were related to Botox.
- U.K. Aesthetic Injectable Market Product Outlook (Revenue, USD Million , 2021-2033)
- Collagen and PMMA Microspheres
- Hyaluronic Acid
- Calcium Hydroxylapatite (CaHA)
- PLLA
- PCL
- PN/PDRN
- Botulinum Toxin (Botox)
- U.K. Aesthetic Injectable Market Application Outlook (Revenue, USD Million , 2021-2033)
- Wrinkle Correction
- Lip Augmentation
- Facial Contouring
- Scar Treatment
- Volume Loss Restoration
- Others
- U.K. Aesthetic Injectable Market End Use Outlook (Revenue, USD Million , 2021-2033)
- MedSpas
- Aesthetic Surgery Centers
- Hospitals
- Others
Reasons to subscribe to Aesthetic Injectable Market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Aesthetic Injectable Market databook
- Our clientele includes a mix of Aesthetic Injectable Market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Aesthetic Injectable Market, including forecasts for subscribers. This country databook contains high-level insights into U.K. Aesthetic Injectable Market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.K. Aesthetic Injectable Market, 2021-2033 (US$M)
UK Product - Aesthetic Injectable Market, 2025 - 2033 (US$M)
